Findings from a recently presented study demonstrated that patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors (GEP-NETs) may benefit from treatment with Afinitor ...

Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

Cipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth.

The organization that runs a supervised injection site in New Brunswick says their work is saving lives and it's disappointing P.E.I. has decided not to open a similar site for now. P.E.I. health ...

P.E.I.'s chief public health officer says the province has decided to pause the establishment of a supervised injection site and instead prioritize strengthening its existing harm reduction ...

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

Before injecting Nucala, you’ll need to clean the injection site with an alcohol swab and let it air-dry. Do not touch the injection site again until after your injection. Be sure to avoid ...

Cipla is also gradually building market share in Lanreotide injections. Albuterol, Lanreotide, gRevlimid, and Brovana are projected to contribute stable sales of $238 million in the US market, with ...

The "Lanreotide Injection Market"is anticipated to increase from USD xxx billion in 2023 to USD xxx billion by 2031, with a strong compound annual growth rate (CAGR) of xxx% from 2024 to 2031. This ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.